SCHEMBL8779104

SCHEMBL8779104

C=C1c2cc(Cl)cc(Cl)c2CCC12CCCC2

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 1/20 0.35
NOTUM Q6P988 1/20 0.33
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8778955 0.84 AR (0.33)
SCHEMBL8778968 0.80 MEN1 (0.36) ADRA2ANOTUM
SCHEMBL8779060 0.77 KDM1A (0.37) ADRA2A
SCHEMBL8779056 0.73 F7 (0.39)
SCHEMBL8778969 0.72 KDM1A (0.34)
SCHEMBL8779058 0.70 METAP1 (0.40)
SCHEMBL8779032 0.65 AR (0.33)
SCHEMBL8779076 0.63 PNMT (0.34) ADRA2A
SCHEMBL7815325 0.62 MEN1 (0.49) NOTUMALDH1A1
SCHEMBL2256507 0.61 MEN1 (0.52) NOTUMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0606661-B1 Octahydrophenanthrene derivatives and their use as NMDA-Antagonists HOFFMANN LA ROCHE (CH) 1997-03-12 EP disclosed
US-5385947-A For prevention of nerve damage due to reduction of blood or oxygen supplies HOFFMANN-LA ROCHE INC. (US) 1995-01-31 US disclosed
EP-0606661-A1 Octahydrophenanthrene derivatives and their use as NMDA-Antagonists F. HOFFMANN-LA ROCHE AG (CH) 1994-07-20 EP disclosed